Surgical research in urology and renal trasplantation
Search for publications
Only original articles, editorials, guidelines.
-
Corvino R, Basile G, Santarelli V, Asero V, De Berardinis E, Sciarra A, Vittori L, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Barod R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Suleja A, Grobet-Jeandin E, Mari A, Mertens LS, Moschini M, De Angelis M, Scillipoti P, Soria F, Bosio A, Teoh J, Claps F, Amodeo A, Slusarczyk A, Contieri R, Subiela D, Tagalos A, Tully KH, Pichler R, Antonelli A, Bertolo R, Veccia A, Malandra S, Hurle R, Sormani F, Crocetto F, Mayr R, Porreca A, Simone G, Tuderti G, Rocco B, Simonato A, Simonato FA, Marcq G, Gontero P, Tian Z, Karakiewicz P, Chung BI, Pradere B, Del Giudice F.
Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . : .
-
Sridharan K, Fiala O, Sivaramakrishnan G, Matrana MR, Büttner T, Kucharz J, Molina Cerrillo J, Giannatempo P, Myint ZW, Gómez de Liaño A, Pirshtuk A, Mota A, Kanesvaran R, Ürün Y, Angel M, Soule T, Massari F, Bellmunt J, Gupta S, Santoni M.
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
EXPERT OPINION ON BIOLOGICAL THERAPY . : 1-11.
-
Fernández-Mardomingo Díaz A, Mínguez Ojeda C, Del Peso AC, Subiela Henríquez JD, de la Parra I, Vázquez Valdés S, Crespo Martínez L, Burgos Revilla FJ.
Urinary Functional Outcomes and Prolapse Recurrence After Laparoscopic Sacrocolpopexy: A 400-Patient Single-Centre Study.
INTERNATIONAL UROGYNECOLOGY JOURNAL . : .
-
Fernández IP, Lorenzo VB, Dominguez RG, Gómez CI, Molina-Cerrillo J, Carbonero IG, Feliciangeli E, Ruiz SG, de Liaño AG, Valderrama BP, Sánchez ÁR, Morcuende RS, Rodríguez CS, Quintela MEL, Díaz EG, Padró JGI, Puente J, Guzman JCV, Sanchez JG, Kareaga MM, Zambrana MDCB, de Velasco G, Cabrero IR, García-Donas J, Munarriz J, Sarrió RG, Núñez NF, Gordoa TA, Esteban E.
Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study).
Clinical & Translational Oncology . : .